Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 753–754 | Cite as

ASO Author Reflections: Survival Impacts of Therapy and Complications in Gastric Adenocarcinoma

  • Diego Vicente
  • Naruhiko Ikoma
  • Brian D. BadgwellEmail author
ASO Author Reflections



The authors have no conflicts of interest to disclose.


  1. 1.
    Jin LX, Sanford DE, Squires MH, 3rd, et al. Interaction of postoperative morbidity and receipt of adjuvant therapy on long-term survival after resection for gastric adenocarcinoma: results from the U.S. Gastric Cancer Collaborative. Ann Surg Oncol. 2016;23(8):2398–408.CrossRefGoogle Scholar
  2. 2.
    Mota JM, Leite CA, Souza LE, et al. Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4/CXCL12 and favors tumor progression in mice. Cancer Immunol Res. 2016;4(4):312–22.CrossRefGoogle Scholar
  3. 3.
    Eguchi T, Kodera Y, Nakanishi H, et al. The effect of chemotherapy against micrometastases and isolated tumor cells in lymph nodes: an in vivo study. In Vivo. 2008;22(6):707–12.Google Scholar
  4. 4.
    Vicente D, Ikoma N, Chiang YJ, et al. Preoperative therapy for gastric adenocarcinoma is protective for poor oncologic outcomes in patients with complications after gastrectomy. Ann Surg Oncol. 2018;25(9):2720–30.CrossRefGoogle Scholar
  5. 5.
    Eto K, Hiki N, Kumagai K, et al. Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications. Gastric Cancer. 2018;21(4):703–9.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Diego Vicente
    • 1
  • Naruhiko Ikoma
    • 2
  • Brian D. Badgwell
    • 2
    Email author
  1. 1.The Department of Surgery at Uniformed ServicesUniversity of the Health Sciences & The Walter Reed National Military Medical CenterBethesdaUSA
  2. 2.Department of Surgical OncologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations